Allianz Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-83,245
| Closed | -$1.3M | – | 2017 |
|
|
2020
Q4 | $1.3M | Buy |
+83,245
| New | +$1.3M | ﹤0.01% | 1412 |
|
|
2020
Q1 | – | Sell |
-167,063
| Closed | -$1.4M | – | 2186 |
|
|
2019
Q4 | $1.4M | Buy |
167,063
+8,025
| +5% | +$67.2K | ﹤0.01% | 1597 |
|
|
2019
Q3 | $1.45M | Buy |
159,038
+47
| +0% | +$427 | ﹤0.01% | 1561 |
|
|
2019
Q2 | $1.71M | Sell |
158,991
-120,924
| -43% | -$1.3M | ﹤0.01% | 1584 |
|
|
2019
Q1 | $2.67M | Sell |
279,915
-50,564
| -15% | -$482K | ﹤0.01% | 1470 |
|
|
2018
Q4 | $3.77M | Sell |
330,479
-48,068
| -13% | -$548K | ﹤0.01% | 1258 |
|
|
2018
Q3 | $6.42M | Buy |
378,547
+107,872
| +40% | +$1.83M | 0.01% | 1175 |
|
|
2018
Q2 | $3.84M | Buy |
270,675
+27,033
| +11% | +$384K | ﹤0.01% | 1298 |
|
|
2018
Q1 | $4.63M | Buy |
243,642
+137,050
| +129% | +$2.6M | ﹤0.01% | 1239 |
|
|
2017
Q4 | $1.75M | Buy |
+106,592
| New | +$1.75M | ﹤0.01% | 1579 |
|
|
2015
Q3 | – | Sell |
-86,405
| Closed | -$959K | – | 1921 |
|
|
2015
Q2 | $959K | Sell |
86,405
-591,923
| -87% | -$6.57M | ﹤0.01% | 1549 |
|
|
2015
Q1 | $10.6M | Sell |
678,328
-20,067
| -3% | -$315K | 0.01% | 803 |
|
|
2014
Q4 | $10.6M | Buy |
698,395
+395,104
| +130% | +$6.01M | 0.01% | 778 |
|
|
2014
Q3 | $3.27M | Sell |
303,291
-7,122
| -2% | -$76.8K | ﹤0.01% | 1058 |
|
|
2014
Q2 | $4.74M | Sell |
310,413
-17,301
| -5% | -$264K | 0.01% | 942 |
|
|
2014
Q1 | $5.93M | Sell |
327,714
-9,147
| -3% | -$165K | 0.01% | 903 |
|
|
2013
Q4 | $4.68M | Sell |
336,861
-9,496
| -3% | -$132K | 0.01% | 957 |
|
|
2013
Q3 | $3.63M | Buy |
346,357
+24,257
| +8% | +$254K | ﹤0.01% | 1006 |
|
|
2013
Q2 | $2.52M | Buy |
+322,100
| New | +$2.52M | ﹤0.01% | 1123 |
|